🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

47+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 47 recruiting trials for “pulmonary-arterial-hypertension

Phase 2, PHASE3RecruitingNCT06683040

Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

👨‍⚕️ Tamila V Martynyuk, MD, E.I.Chazov Cardiology Center📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT06454838

Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension

👨‍⚕️ Meral BOŞNAK GÜÇLÜ, Prof. Dr., Gazi University📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06476470

Taiwan Interstitial Lung Disease Multi-center Investigation and Registry

👨‍⚕️ Pin-Kuei Fu, MD., Ph.D, Taichung Veterans General Hospital📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06053580

Repurposing Valsartan May Protect Against Pulmonary Hypertension

👨‍⚕️ Peter Leary, MD, PhD, University of Washington📍 1 site📅 Started Feb 2024View details ↗
Phase 4RecruitingNCT06317805

Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

🏥 AOP Orphan Pharmaceuticals AG📍 19 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT04778046

Pulmonary Hypertension SOLAR

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke University📍 1 site📅 Started Nov 2023View details ↗
NARecruitingNCT06605794

FreeFlow Percutaneous Atrial Septal Shunt for IPAH

👨‍⚕️ Junbo GE, Prof., Fudan University📍 1 site📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT05824923

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

👨‍⚕️ Yaling Han, The General Hospital of Northern Theater Command📍 1 site📅 Started Aug 2023View details ↗
Phase 4RecruitingNCT05825417

Pulmonary Hypertension: Intensification and Personalisation of Combination Rx

👨‍⚕️ Alexander Rothman, MD / PhD, University of Sheffield📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05587712

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 35 sites📅 Started Jan 2023View details ↗
RecruitingNCT05462574

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

👨‍⚕️ Evan Brittain, MD, MSCI, Vanderbilt University Medical Center📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05665556

REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)

👨‍⚕️ Jose Luis Hernandez Oropeza, PhD, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran📍 1 site📅 Started Dec 2022View details ↗
NARecruitingNCT05584722

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

👨‍⚕️ Evan Brittain, MD, Vanderbilt Medical Center📍 1 site📅 Started Nov 2022View details ↗
EARLY_Phase 1RecruitingNCT05452889

PET Image in PAH Patients

👨‍⚕️ Stephen Chan, University of Pittsburgh📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05566002

Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension

👨‍⚕️ Zhihong Liu, MD, PhD, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College📍 1 site📅 Started Jun 2022View details ↗
NARecruitingNCT05413109

COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina

👨‍⚕️ Fabio Dardi, PhD, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna (Italy)📍 1 site📅 Started May 2022View details ↗
RecruitingNCT05368467

National Registry and Cohort Study of Pulmonary Vascular Disease

🏥 Nanjing First Hospital, Nanjing Medical University📍 13 sites📅 Started Mar 2022View details ↗
RecruitingNCT04756076

Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients

🏥 Jiapeng Huang📍 1 site📅 Started Dec 2020View details ↗
Phase 3Enrolling by InvitationNCT03683186

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

🏥 United Therapeutics📍 190 sites📅 Started Sep 2019View details ↗
Phase 3RecruitingNCT04062565

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

👨‍⚕️ Franz Rischard, DO, University of Arizona📍 1 site📅 Started Mar 2019View details ↗
← PreviousPage 2 of 3Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →